Title : Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical beta-Blockers - Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
Author(s) : Baker JG , Fromont C , Bruder M , Thompson KSJ , Kellam B , Hill SJ , Gardiner SM , Fischer PM |
Ref : ACS Pharmacol Transl Sci , 3 :737 , 2020 |
Abstract : Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
ESTHER : Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
PubMedSearch : Baker_2020_ACS.Pharmacol.Transl.Sci_3_737 |
PubMedID: 32832874 |